Volume 7, Number 2—April 2001
THEME ISSUE
4th Decennial International Conference on Nosocomial and Healthcare-Associated Infections
State of the Art
Molecular Approaches to Diagnosing and Managing Infectious Diseases: Practicality and Costs
Michael A. Pfaller
Table 2
Noncommercial nucleic acid-based tests for clinically important viral and bacterial pathogensa
| Organism | Specimen type | Clinical indication |
|---|---|---|
| Epstein-Barr virus (EBV) | Cerebrospinal fluid (CSF) | EBV lymphoproliferative disorder |
| Herpes simplex virus (HSV) types 1 and 2 | CSF Vitreous humor | Encephalitis |
| Varicella-zoster virus (VZV) | Various tissues | VZV reactivation |
| JC virus | CSF | Progressive multifocal leukoencephalopathy |
| Enterovirus | CSF | Aseptic meningitis |
| Parvovirus B19 | Amniotic fluid Serum | Hydrops fetalis Anemia |
| Adenovirus | Urine Tissues Blood | Immunocompromised patients, transplant recipients |
| Ehrlichia | Blood | Human granulocytic and monocytic ehrlichiosis |
| Bordetella pertussis | Nasopharyngeal aspirate | Whooping cough |
| Legionella pneumophila | Respiratory | Atypical pneumonia |
| Chlamydia pneumoniae | Respiratory | Atypical pneumonia |
| Mycoplasma pneumoniae | Respiratory | Atypical pneumonia |
| Helicobacter pylori | Gastric fluid Stool | Peptic ulcer disease |
aAll tests use polymerase chain reaction. The list is not all-inclusive.
Page created: May 10, 2011
Page updated: May 10, 2011
Page reviewed: May 10, 2011
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.